The incidence of sepsis is increasing and remains the leading cause of death in critically ill patients. The statin group of drugs appear to have important antiinflammatory effects and may have a role in the treatment of sepsis. However, current prescribing guidelines recommend that statin therapy is discontinued in critically ill patients. We found no evidence to support commencing statin therapy in patients with sepsis on an intensive care unit and low levels of evidence to support continuing established therapy in this patient population.
AnnaneD., AegerterP., Jars-GuincestreM.C.Current epidemiology of septic shock: the CUB- Rea Network.Am J Respir Crit Care Med2003; 168: 165–172.
2.
BernardG.R., VincentJ.L., LaterreP.F.Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med2001; 334: 699–709.
3.
DunzendorferS., RothbucherD., SchratzbergerP.Mevalonate dependant inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin.Circ Res1997; 81: 963–969.
4.
TerblancheM., AlmogY., RosensonR.S.Statins: panacea for sepsis?Lancet Infect Dis2006; 6: 242–248.
5.
MerxM.W., LiehnE.A., JanssensU.HMG Co-A reductase inhibitor Simvastatin profoundly improves survival in a murine model of sepsis.Circulation2004; 109: 2560–2565.
6.
DiehlJ.L., BorgelD.Sepsis and Coagulation.Curr Opin Crit Care2005; 11: 454–460.
7.
DurantR., KloucheK., DelboscS.Superoxide anion overproduction in sepsis: effects of vitamin E and simvastatin.Shock2004; 22: 34–39.
8.
MIMS Online (2006). Prescribing information Atorvastatin, Fluvastatin, Simvastatin, http://www.mims.com.au Accessed October 2006.
9.
ThomsenR.W., HundborgH.H., JohnsenS.P., PedersenL., SorensenH.T., SchonheyderH.C.Statin use and mortality within 180 days after bacteremia: a population-based cohort study.Crit Care Med2006; 34: 1080–1086.
10.
LiappisA.P., KanV.L., RochesterC.G.The effect of statins on mortality in patients with bacteremia.Clinical Infectious Diseases2001; 33: 1352–1357.
11.
KrugerP., FitzsimmonsK., CookD.Statin therapy is associated with fewer deaths in patients with bacteraemia.Intensive Care Med2006; 32: 75–79.
12.
MortensenE.M., RestrepoM.I., AnzuetoA.The effect of prior statin use on 30 day mortality for pateints hospitilized with community acquired pneumonia.Respiratory Research2005; 6: 82–89.
13.
GuytonJ.R.Benefit versus risk in statin treatment.Am J Cardiol2006; 97: 95C–97C.
